Top Markets
Coin of the day
Bioasis Technologies Inc. Bioasis Technologies Inc.

Bioasis Technologies Inc.

BTI
Rang in aandelen #39944
Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused... Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused on innovating diagnostic methods and therapeutic solutions for a range of neurological conditions. The company's primary technological asset is the xB3 platform, engineered to enable the transport of medicinal compounds across the often-impenetrable blood-brain barrier. This capability is crucial for addressing central nervous system disorders, including various brain cancers, metabolic dysfunctions, and neurodegenerative illnesses. Bioasis is actively advancing its in-house pipeline with programs such as xB3-001 for brain metastases, xB3-002 for glioblastoma, and xB3-007 for neurodegenerative diseases, all designed to offer both symptomatic relief and disease-modifying benefits. The company has also established numerous strategic alliances. These include a partnership with Aposense Limited to deliver siRNA therapeutics for CNS disorders; a collaboration with Oxyrane UK Ltd. to combine the xB3 technology with Oxyrane's OxyCAT platform for enhanced enzyme replacement therapy targeting the brain; an agreement with Janssen Biotech, Inc. for the discovery, development, and commercialization of novel products leveraging the xB3 platform; and a research and licensing deal with Neuramedy Co Ltd. to develop and market an xB3-enhanced version of their antibody, Tomaralimab. Founded in 2006, Bioasis Technologies Inc. is headquartered in New Haven, Connecticut.
Aandeelprijs
$0.00366968
Laatst gesynchroniseerd: 2024-07-23
Marktkapitalisatie
$291.42K
Verandering (1 dag)
-0.81%
Verandering (1 jaar)
0.00%
Land
US
Handel Bioasis Technologies Inc. (BTI)

Categorie

Prijs BTI met de marktkapitalisatie van B
Bioasis Technologies Inc. Bioasis Technologies Inc.
BTI
$0.00366968
Marktkapitalisatie van Bioasis Technologies Inc.(BTI)
Marktkapitalisatie: $291.42K
Vanaf August 2026 heeft Bioasis Technologies Inc. een marktkapitalisatie van $291.42K. Dit maakt Bioasis Technologies Inc. volgens onze gegevens het 39944th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Bioasis Technologies Inc. van 2008 tot 2026
BTI vergeleken met de top 5 populairste stocks
Prijs voor BTI Aandeel B Marktkapitalisatie van B uitslagen
Bioasis Technologies Inc. Bioasis Technologies Inc.
$68,873.72 $291.42K
$5.470T +1,876,829,455.54%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$56,250.42 $291.42K
$4.467T +1,532,840,809.29%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$52,564.87 $291.42K
$4.174T +1,432,408,272.84%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$46,592.25 $291.42K
$3.700T +1,269,652,791.00%
Bioasis Technologies Inc. Bioasis Technologies Inc.
$35,942.56 $291.42K
$2.854T +979,445,505.37%